0001501134-20-000083.txt : 20201120
0001501134-20-000083.hdr.sgml : 20201120
20201120211355
ACCESSION NUMBER: 0001501134-20-000083
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201118
FILED AS OF DATE: 20201120
DATE AS OF CHANGE: 20201120
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Guyer Shelly D
CENTRAL INDEX KEY: 0001588984
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36847
FILM NUMBER: 201334114
MAIL ADDRESS:
STREET 1: 1025 GREEN STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94133
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Invitae Corp
CENTRAL INDEX KEY: 0001501134
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 271701898
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1400 16TH STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
BUSINESS PHONE: (415) 374-7782
MAIL ADDRESS:
STREET 1: 1400 16TH STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
FORMER COMPANY:
FORMER CONFORMED NAME: InVitae Corp
DATE OF NAME CHANGE: 20121105
FORMER COMPANY:
FORMER CONFORMED NAME: Locus Development Inc
DATE OF NAME CHANGE: 20100910
4
1
wf-form4_160592482126942.xml
FORM 4
X0306
4
2020-11-18
0
0001501134
Invitae Corp
NVTA
0001588984
Guyer Shelly D
C/O INVITAE CORPORATION
1400 16TH STREET
SAN FRANCISCO
CA
94103
0
1
0
0
Chief Financial Officer
Common Stock
2020-11-18
4
S
0
1513
46.20
D
226007
D
Common Stock
2020-11-18
4
S
0
1187
47.17
D
224820
D
Common Stock
2020-11-18
4
S
0
300
47.91
D
224520
D
The sales of common stock was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 8, 2020.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.69 to $46.65, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
Includes an aggregate of 161,973 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $46.73 to $47.53, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.80 to $48.05, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
/s/ Thomas Brida, Attorney-in-fact
2020-11-20